Effects of Serdexmethylphenidate/dexmethylphenidate on growth and sleep in children and adolescents with ADHD: a plain language summary
This Plain Language Summary of Publication article (PLSP) from Future Neurology, highlights findings from two studies on SDX/d-MPH (Azstarys®), a medication for ADHD in individuals aged six and older. One study explored the medication’s impact on children’s growth rates, while the other examined its effects on sleep quality as reported by parents.
Visit the site using this link to read the article.
This PLSP is based on two articles called ‘Analysis of Growth Velocity in Children with Attention-Deficit/Hyperactivity Disorder Treated for up to 12 Months with Serdexmethylphenidate/Dexmethylphenidate’ published in Journal of Child and Adolescent Pscyhopharmacology and ‘Serdexmethylphenidate/dexmethylphenidate effects on sleep in children with attention-deficit/hyperactivity disorder’ and was published in Frontiers in Psychiatry.
Visit Liebert Publishers using the link to read the original article.
Visit Frontiers using the link to read the original article.